Protocol No.: COG-ANBL2131

Title
A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma
Principal Investigator
Meyer, Ashley
Phase
III
Age Group
Children
Applicable Disease Sites
Brain Cancer
Pediatric Cancer
Participating Institutions
Mary Babb Randolph Cancer Center
West Virginia University
Contact
Abby Swiger, RN
Research Nurse
Phone: +1 304-293-1683

View on ClinicalTrials.gov